Jefferies Group LLC Intellia Therapeutics, Inc. Put Options Transaction History

Jefferies Group LLC

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Sep 21, 2023	SELL	$53.92 - $71.7 $4.72 Million - $6.27 Million	-87,500 Reduced 87.5%	12,500 $699,000
Q3 2022 Nov 14, 2022	SELL	$53.92 - $71.7 $4.72 Million - $6.27 Million	-87,500 Reduced 87.5%	12,500 $700,000
Q2 2022 Sep 21, 2023	BUY	$38.49 - $76.21 $134,715 - $266,735	3,500 Added 3.63%	100,000 $5.18 Million
Q2 2022 Aug 15, 2022	BUY	$38.49 - $76.21 $134,715 - $266,735	3,500 Added 3.63%	100,000 $5.18 Million
Q1 2022 Sep 21, 2023	BUY	$58.27 - $118.99 $1.17 Million - $2.38 Million	20,000 Added 26.14%	96,500 $7.01 Million
Q1 2022 May 16, 2022	BUY	$58.27 - $118.99 $1.17 Million - $2.38 Million	20,000 Added 26.14%	96,500 $7.01 Million
Q4 2021 Sep 21, 2023	BUY	$100.76 - $138.36 $6.99 Million - $9.6 Million	69,400 Added 977.46%	76,500 $9.05 Million
Q4 2021 Feb 14, 2022	BUY	$100.76 - $138.36 $6.99 Million - $9.6 Million	69,400 Added 977.46%	76,500 $9.05 Million
Q3 2021 Sep 21, 2023	SELL	$132.37 - $176.78 $291,214 - $388,916	-2,200 Reduced 23.66%	7,100 $952,000
Q3 2021 Nov 15, 2021	SELL	$132.37 - $176.78 $291,214 - $388,916	-2,200 Reduced 23.66%	7,100 $952,000
Q2 2021 Sep 21, 2023	SELL	$60.88 - $161.91 $194,816 - $518,112	-3,200 Reduced 25.6%	9,300 $1.51 Million
Q2 2021 Aug 20, 2021	SELL	$60.88 - $161.91 $56.1 Million - $149 Million	-920,700 Reduced 99.0%	9,300 $1.51 Million
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $56.6 Million - $151 Million	930,000 New	930,000 $1.51 Million

326

88.8M

673K

865K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.56B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.